Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Problems when switching antipsychotics].

Ugeskrift for laeger·2012

Same author

Drug therapy of dementia in elderly patients. A review.

Nordic journal of psychiatry·2005

Same author

[Diabetes as a complication in treatment with second-generation antipsychotics].

Ugeskrift for laeger·2004

Same author

[Diagnosis and treatment of depression in general practice. A questionnaire study].

Ugeskrift for laeger·2002

Same author

[Why is QT interval interesting?].

Ugeskrift for laeger·2002

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

[Paliperidone--a novel second-generation antipsychotic].

Kamilla Maknyte¹, Henrik K F Lublin

¹Region Hovedstaden Psykiatri, Psykiatrisk Center Glostrup, Glostrup.

Ugeskrift for Laeger

|September 3, 2008

Summary

This summary is machine-generated.

Paliperidone ER (PAL ER), a new antipsychotic, showed significant effectiveness compared to placebo in clinical trials. However, direct comparisons with risperidone are lacking, making it impossible to determine if PAL ER is superior.

More Related Videos

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Published on: February 16, 2024

Related Experiment Videos

Last Updated: Jul 2, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Published on: February 16, 2024

Area of Science:

Pharmacology
Clinical Psychiatry
Drug Development

Background:

Paliperidone ER (PAL ER) is a novel second-generation antipsychotic.
Its pharmacodynamics are similar to risperidone.
PAL ER exhibits a slow, smooth 24-hour release and a half-life of approximately 24 hours, primarily excreted unchanged in urine.

Purpose of the Study:

To evaluate the efficacy and tolerability of Paliperidone ER (PAL ER).
To compare PAL ER against placebo in treating relevant conditions.
To identify the optimal dosage range for PAL ER.

Main Methods:

Three short-term efficacy studies.
One relapse prevention study.
Dose range evaluated: 3-15 mg once daily.

Main Results:

PAL ER demonstrated statistically significant efficacy over placebo across all tested doses.
No adverse events were specifically detailed in the provided abstract.
No head-to-head trials comparing PAL ER with other antipsychotics, including risperidone, were identified.

Conclusions:

Paliperidone ER (PAL ER) is an effective treatment option compared to placebo.
Further research, including head-to-head trials, is needed to compare PAL ER with existing antipsychotics like risperidone.
Current evidence is insufficient to establish the comparative efficacy or tolerability of PAL ER versus risperidone.